Insider · CIK 0001965808
Ingrid Delaet
officer
Files at NBIX (NEUROCRINE BIOSCIENCES INC). First filing Dec 19, 2024, latest Jul 11, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $576k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NBIX: NEUROCRINE BIOSCIENCES INC
NBIXOct 9, 2026 · close 142.44
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | NEUROCRINE BIOSCIENCES INC | $62k 457 shares | -9% | +54% from low-12% from high | |
| 16Weak | NEUROCRINE BIOSCIENCES INC | $172k 1,471 shares | -31% | - | |
| 16Weak | NEUROCRINE BIOSCIENCES INC | $158k 1,045 shares | -32% | - | |
| 0Weak | NEUROCRINE BIOSCIENCES INC | $38k 272 shares | -10% | - | |
| 1Weak | NEUROCRINE BIOSCIENCES INC | $147k 1,091 shares | -30% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 31, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | 272 0.00% of outstanding | $37k | Dec 31, 2024 | $147k |
| Dec 17, 2024 | NBIX NEUROCRINE BIOSCIENCES, INC. | 1,091 0.00% of outstanding | $145k | Dec 17, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +4,483 | $0.00 | $0 | 20,708 | 27 d ago |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -2,419 | $156.22 | $378k | 18,289 | 27 d ago |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +1,600 | $0.00 | $0 | 6,656 | Feb 17, 2026 |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -881 | $123.10 | $108k | 5,775 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +1,401 | $0.00 | $0 | 7,176 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -756 | $124.12 | $94k | 6,420 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +1,359 | $0.00 | $0 | 7,779 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -734 | $124.12 | $91k | 7,045 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +19,935 | $0.00 | $0 | 26,980 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -10,755 | $124.12 | $1.3M | 16,225 | Feb 17, 2026 |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -1,600 | $0.00 | $0 | 4,801 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -1,401 | $0.00 | $0 | 2,802 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -1,359 | $0.00 | $0 | 1,359 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative | +31,234 | $0.00 | $0 | 31,234 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative | +5,479 | $0.00 | $0 | 5,479 | Feb 17, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +801 | $0.00 | $0 | 5,531 | Feb 3, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -475 | $136.06 | $65k | 5,056 | Feb 3, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restriced Stock Unitderivative | -801 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jul 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +457 | $79.02 | $36k | 5,187 | Jul 11, 2025 |
| Jul 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -457 | $135.00 | $62k | 4,730 | Jul 11, 2025 |
| Jul 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Non-Qualified Stock Optionderivative10b5-1 | -457 | $0.00 | $0 | 2,261 | Jul 11, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,358 | $0.00 | $0 | 4,800 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -716 | $116.69 | $84k | 4,084 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,401 | $0.00 | $0 | 5,485 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -755 | $116.72 | $88k | 4,730 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative10b5-1 | +34,153 | $0.00 | $0 | 34,153 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative10b5-1 | +6,401 | $0.00 | $0 | 6,401 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,358 | $0.00 | $0 | 2,718 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,401 | $0.00 | $0 | 4,203 | Feb 14, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +801 | $0.00 | $0 | 3,308 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -422 | $153.05 | $65k | 2,886 | Feb 4, 2025 |
| Feb 3, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,179 | $0.00 | $0 | 4,065 | Feb 4, 2025 |
| Feb 3, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -623 | $149.29 | $93k | 3,442 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restriced Stock Unitderivative10b5-1 | -801 | $0.00 | $0 | 801 | Feb 4, 2025 |
| Feb 3, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,179 | $0.00 | $0 | 0 | Feb 4, 2025 |
| Dec 31, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +272 | $79.02 | $21k | 2,779 | Jan 3, 2025 |
| Dec 31, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -272 | $138.10 | $38k | 2,507 | Jan 3, 2025 |
| Dec 31, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Non-Qualified Stock Optionderivative10b5-1 | -272 | $0.00 | $0 | 2,718 | Jan 3, 2025 |
| Dec 17, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,091 | $79.02 | $86k | 3,598 | Dec 19, 2024 |
| Dec 17, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,091 | $135.00 | $147k | 2,507 | Dec 19, 2024 |
| Dec 17, 2024 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Non-Qualified Stock Optionderivative10b5-1 | -1,091 | $0.00 | $0 | 2,990 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.